
E-Journal of Chemistry p. 1346 - 1354 (2011)
Update date:2022-08-05
Topics:
Mathew, Glory
Krishnan
Antony, Molly
Suseelan
Copper(II) complexes of chromen-2-one-3-carboxyhydrazide and 2-(chromen-3'-onyl)-5-(aryl)-1,3,4-oxadiazole derivatives have been synthesized. The structural features have been determined from their microanalytical, magnetic susceptibility, molar conductance, IR, UV Vis, 1H NMR and ESR spectral data. All the Cu(II) complexes exhibit the composition Cu(Ln) 2X2; where L1= chromen-2-one-3-carboxy hydrazide, L2 = 2-(chromen-3'-onyl)- 5-(2"-hydroxy phenyl)-1,3,4-oxadiazole, L3 = 2-(chromen-3'-onyl)-5-(4"- nitrophenyl)-1,3,4 -oxadiazole and L4 = 2-(chromen-3'-onyl)-5-(4"- chlorophenyl)-1,3,4-oxadiazole; X = Cl-, Br-, NO3 -, CH3COO-, ClO4 - and CNS-. The N, O donor ligands act as a bidentate ligand in all the complexes. Distorted octahedral geometry for all the Cu(II) complexes is proposed. Molecular modeling studies have been made for the rapid structure building, geometry optimization and molecular display. These complexes show the conductance values, supporting their non-electrolytic nature. The monomeric nature of the complexes was confirmed from their magnetic susceptibility values. These complexes have been screened for their antimicrobial activities against some bacterial species like S.aureus, E.coli, Pseudomonas aeruginosa and few fungal strains C.albicans and Cryptococcus neoformans.
View MoreJIANGXI ZHANGFENG CHEMICAL CO., LTD.
Contact:+86-0799-3413066
Address:Xiyuan village, Xiabu Town, Xiangdong District
Luoyang Aoda chemical Co.,Ltd.
Contact:+86-379-67518785 67516588
Address:MiaoWan industry district,YanShi City,Henan,China
Shanghai Norky Pharmaceutical Co., LTD.
website:http://www.norkypharm.com
Contact:86-21-61075300
Address:1165 Jiangning Road, Office 1502, Shanghai, China
Twin International Co., Limited
Contact:+86-21-80309280
Address:No.345 Jinxiang Road, Jinqiao Export Processing Zone
Jinhua Haoyuan Chemical CO., LTD(expird)
Contact:86-579-82465583
Address:Jinhua,Zhejiang
Doi:10.1039/j29710001988
(1971)Doi:10.1016/S0960-894X(00)00465-0
(2000)Doi:10.7164/antibiotics.53.1086
(2000)Doi:10.1021/jo0000170
(2000)Doi:10.1021/jo00822a016
(1971)Doi:10.1039/j39710000861
(1971)